Home › Novartis selling nicotine patch to win U.S. nod for GlaxoSmithKline deal - FTC
 

Keywords :   


Novartis selling nicotine patch to win U.S. nod for GlaxoSmithKline deal - FTC

2014-11-26 21:55:46| Biotech - Topix.net

Switzerland's Novartis AG has agreed to sell its nicotine patch, Habitrol, in order to win U.S. antitrust approval for a consumer healthcare joint venture with Britain's GlaxoSmithKline , the U.S. Federal Trade Commission said on Wednesday. The deal is part of a three-way transaction unveiled in April, which includes GSK buying Novartis' vaccines business, Novartis purchasing GSK's cancer drugs, and the two groups tying up in consumer healthcare.

Tags: win deal selling patch

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
30.06Hurricane Beryl Update Statement
30.06Summary for Hurricane Beryl (AT2/AL022024)
30.06Hurricane Beryl Graphics
30.06Hurricane Beryl Forecast Discussion Number 8
30.06Hurricane Beryl Public Advisory Number 8
30.06Hurricane Beryl Wind Speed Probabilities Number 8
30.06Hurricane Beryl Forecast Advisory Number 8
30.06Weekly Recap: Rockline Wins WOW Innovation Award, Hospeco Purchases Nuance Solutions & More
More »